Search research articles
Contact Us
Filters
Showing results (161-170 of 224) with videos related to
Page
of 23
Sort By:
Molecular Pharmacology
|
March 3, 1999
G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study
A Newman-Tancredi, D Cussac, V Audinot, et al.
European Journal of Pharmacology
|
December 28, 1999
The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study
A Newman-Tancredi, J Rivet, C Chaput, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 20, 2000
Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents
M J Millan, A Gobert, K Bervoets, et al.
Journal of Neuroscience Research
|
March 4, 2000
Activation of dopamine D(3) receptors induces c-fos expression in primary cultures of rat striatal neurons
B J Morris, A Newman-Tancredi, V Audinot, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 1, 2000
Antagonist properties of the novel antipsychotic, S16924, at cloned, human serotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol
D Cussac, A Newman-Tancredi, J P Nicolas, et al.
European Journal of Pharmacology
|
July 21, 1994
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors
F Lejeune, V Audinot, A Gobert, et al.
Neuropeptides
|
February 1, 1985
Chronic pain in the rat: selective alterations in CNS and pituitary pools of dynorphin as compared to vasopressin
M J Millan, M H Millan, C W Pilcher, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 1999
S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine
M J Millan, R Schreiber, S Monneyron, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1995
Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats
A Gobert, F Lejeune, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2008
Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques
N P Visanji, S H Fox, T H Johnston, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 224) with videos related to
Sort By:
Page
of 23
Molecular Pharmacology
|
March 3, 1999
G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study
A Newman-Tancredi, D Cussac, V Audinot, et al.
European Journal of Pharmacology
|
December 28, 1999
The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study
A Newman-Tancredi, J Rivet, C Chaput, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 20, 2000
Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents
M J Millan, A Gobert, K Bervoets, et al.
Journal of Neuroscience Research
|
March 4, 2000
Activation of dopamine D(3) receptors induces c-fos expression in primary cultures of rat striatal neurons
B J Morris, A Newman-Tancredi, V Audinot, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 1, 2000
Antagonist properties of the novel antipsychotic, S16924, at cloned, human serotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol
D Cussac, A Newman-Tancredi, J P Nicolas, et al.
European Journal of Pharmacology
|
July 21, 1994
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors
F Lejeune, V Audinot, A Gobert, et al.
Neuropeptides
|
February 1, 1985
Chronic pain in the rat: selective alterations in CNS and pituitary pools of dynorphin as compared to vasopressin
M J Millan, M H Millan, C W Pilcher, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 1999
S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine
M J Millan, R Schreiber, S Monneyron, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1995
Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats
A Gobert, F Lejeune, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2008
Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques
N P Visanji, S H Fox, T H Johnston, et al.
Page
of 23